Lumiracoxib
| CAS No. | 220991-20-8 |
|---|---|
| MDL No. | MFCD07186254 |
| MF | C15H13ClFNO2 |
| MW | 293.72 |
| InChI Key | KHPKQFYUPIUARC-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Lumiracoxib is a monocarboxylic acid and amino acid derived from phenylacetic acid, substituted at position 2 with the nitrogen of 2-chloro-6-fluoroaniline and at position 5 with a methyl group. It is a highly selective cyclooxygenase 2 inhibitor and a non-steroidal anti-inflammatory drug. Previously used for osteoarthritis, it was withdrawn due to concerns about hepatotoxicity. It is also an organofluorine, organochlorine, secondary amino, and monocarboxylic acid compound.
| CAS No. | 220991-20-8 |
|---|---|
| Product Name | Lumiracoxib |
Biological Targets
PTGS2
Associated Conditions
rheumatoid arthritis·osteoarthritis·rheumatic disease·osteoarthritis, knee·osteoarthritis, hip
* The information provided here is compiled from public sources and is for reference only.
